Naltrexone Implant for Opioid Use Disorder.

Autor: Edinoff AN; Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA., Nix CA; Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA., Orellana CV; Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA., StPierre SM; School of Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA., Crane EA; School of Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA., Bulloch BT; School of Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA., Cornett EM; Department of Anesthesiology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA., Kozinn RL; Department of Anesthesiology and Pain Management, University of Texas Southwestern, Dallas, TX 75390, USA., Kaye AM; Department of Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA 95211, USA., Murnane KS; Department of Psychiatry and Behavioral Medicine, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA.; Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA.; Louisiana Addiction Research Center, Shreveport, LA 71103, USA., Kaye AD; Department of Anesthesiology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA 71103, USA.

Publikováno v: Neurology international [Neurol Int] 2021 Dec 30; Vol. 14 (1), pp. 49-61. Date of Electronic Publication: 2021 Dec 30.